4//SEC Filing
Merendino Lauren 4
Accession 0001415889-25-022376
CIK 0001845337other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 7:36 PM ET
Size
17.2 KB
Accession
0001415889-25-022376
Insider Transaction Report
Form 4
Merendino Lauren
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-08-15+3,162→ 38,323 total - Exercise/Conversion
Common Stock
2025-08-15+3,687→ 42,010 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-08-15−3,162→ 25,302 total→ Common Stock (3,162 underlying) - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-08-15−3,687→ 33,191 total→ Common Stock (3,687 underlying) - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-08-15−3,687→ 47,939 total→ Common Stock (3,687 underlying) - Exercise/Conversion
Common Stock
2025-08-15+3,687→ 45,697 total - Sale
Common Stock
2025-08-18$6.77/sh−3,766$25,485→ 41,931 total
Footnotes (6)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of RSUs.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $6.65 to $6.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein with regard to the block trade.
- [F4]The RSUs vested as to 1/4th of the total award on August 15, 2024, and the remaining 3/4 of the award vests in 12 substantially equal quarterly installments thereafter on November 15, February 15, May 15 and August 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F5]RSUs do not expire; they either vest or are canceled prior to the vesting date.
- [F6]The RSUs vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Day One Biopharmaceuticals, Inc.
CIK 0001845337
Entity typeother
Related Parties
1- filerCIK 0001855298
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 7:36 PM ET
- Size
- 17.2 KB